Antibiotic susceptibility and mechanisms of β-lactam resistance in 1310 strains of Pseudomonas aeruginosa: A French multicentre study (1996)

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 1, 2000, Pages 133-136

  Cavallo, J D ^a   Fabre, R ^a   Leblanc, F ^b   Nicolas Chanoine, M H ^c   Thabaut, A ^d   Avril, J L ^d   Bebear C ^d   Cluzel, R ^d   Sirot, J ^d   Etienne, J ^d   Monteil, H ^d   Scheftel, J M ^d   Morel, C ^d   Leclercq, R ^d   Andremont, A ^d   Jarlier, V ^d   Philippon, A ^d  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b GlaxoWellcome   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM; BETA LACTAMASE; CEFEPIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORINASE; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; FRANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; CLINICAL TRIAL; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 0033925853     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Courvalin, P. & Soussy, C. J. (1996). Technical recommendations for in vitro susceptibility testing. Clinical Microbiology and Infection 2, Suppl. 1, 511-22.
2. Courvalin, P. & Soussy, C. J. (1996). Statement 1996 CA-SFM. Zone sizes and C.M.I. breakpoints for non fastidious organisms. Clinical Microbiology and Infection 2, Suppl. 1, 546-9.
3. Barthélémy, M., Guionie, M. & Labia, R. (1978). β-Lactamases: determination of their isoelectric points. Antimicrobial Agents and Chemotherapy 13, 695-8.
4. Pitt, T. L., Livermore, D. M., Miller, G., Vatopoulos, A. & Legakis, N. J. (1990). Resistance mechanisms of multiresistant serotype O12 Pseudomonas aeruginosa isolated in Europe. Journal of Antimicrobial Chemotherapy 26, 319-28.
5. Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry 72, 248-54.
6. Thabaut, A., Girardet, M., Bercion, R. & Labia, R. (1993). Expression of the chromosomal class I β-lactamase in 1508 clinical isolates of Pseudomonas aeruginosa. In Program and Abstracts of the Eighteenth International Congress of Chemotherapy, Stockholm, 1993. Abstract 922, p. 276.
7. Bert, F. & Lambert-Zechovsky, N. (1996). Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. Journal of Antimicrobial Chemotherapy 37, 809-13.
8. Scheftel, J. M., Weber, M. & the French USI Group. (1994). Résistance à 16 antibiotiques de 3876 bacilles à Gram négatif aérobies isolés dans 39 centres de soins intensifs en France (1991). Medicine and Infectious Diseases 24, 255-62.
9. Köhler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A. L. & Pechère, J. C. (1997). Differential selection of multidrug efflux Systems by quinolones in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 41, 2540-3.